Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» zanubrutinib
zanubrutinib
BeiGene's first U.S. NDA tests global development strategy
BioCentury
Sat, 08/24/19 - 11:06 am
BeiGene
China
FDA
drug development
zanubrutinib
Upcoming events – Crucial data on zanubrutinib and filgotinib approach
EP Vantage
Fri, 06/14/19 - 10:14 am
BeiGene
Waldenström’s macroglobulinemia
zanubrutinib
Galapagos
filgotinib
CLE
Sjögren’s syndrome
BeiGene Announces Acceptance of its NDA in China for Zanubrutinib in Certain Types of Leukemia and Lymphoma
Wed, 10/24/18 - 11:53 am
BeiGene
zanubrutinib